Filing Flows › Sylvamo (SLVM) › Q3 2026 › vs Q3 2025
Sylvamo (SLVM) Q3 2026 vs Q3 2025 (year over year)
Sylvamo's revenue fell $17.0M (-3%) from $662M in Q3 2025 to $645M in Q3 2026. The biggest changes: North America Segment −$36.0M (-8%); Latin America Segment +$19.0M (+9%).
Sylvamo, Q3 2026: revenue $645M (-3% year over year), operating margin 13.5%, net loss $199M, operating cash flow $64.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 2.8% | 8.9% | -6.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| North America Segment | $414M | $450M | −$36.0M | -8% |
| Latin America Segment | $231M | $212M | $19.0M | +9% |
| Revenue | $645M | $662M | −$17.0M | -3% |
| Income tax benefit | $14.0M | −$34.0M | $48.0M | — |
| Net loss | $199M | −$57.0M | $256M | — |
| Costs & expenses | $858M | $662M | $196M | +30% |
| Operating costs | $558M | $549M | $9.0M | +2% |
| Interest & other, net | $300M | $22.0M | $278M | 14× |
| Cost of revenue | $440M | $443M | −$3.0M | -0.7% |
| SG&A | $82.0M | $61.0M | $21.0M | +34% |
| Other operating costs | $36.0M | $45.0M | −$9.0M | -20% |
| Operating cash sources | $263M | $30.0M | $233M | +777% |
| Depreciation & amortization | $36.0M | $41.0M | −$5.0M | -12% |
| Share-based compensation | $4.0M | $3.0M | $1.0M | +33% |
| Working capital & other | $223M | −$14.0M | $237M | — |
| Net loss absorbed | $199M | −$57.0M | $256M | — |
| Operating cash flow | $64.0M | $87.0M | −$23.0M | -26% |
| Free cash flow (OCF − capex) | $18.0M | $59.0M | −$41.0M | -69% |
| Capital expenditures | $46.0M | $28.0M | $18.0M | +64% |
Questions
How much did Sylvamo's revenue grow year over year in Q3 2026?
Sylvamo's revenue fell $17.0M (-3%) from $662M in Q3 2025 to $645M in Q3 2026.
What drove Sylvamo's revenue change in Q3 2026?
North America Segment −$36.0M (-8%); Latin America Segment +$19.0M (+9%).